Even though Alzheimer's disease (AD) is of significant interest to the scientific community, its
pathogenesis is very complicated and not well-understood. A great deal of progress has …

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by dementia and
abnormal deposits of aggregated amyloid-β in the brain. Recent genome-wide association …

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by a marked
decline in cognition and memory function. Increasing evidence highlights the essential role …

Alzheimer's disease (AD) is a progressive neurodegenerative disease without effective
therapy. Brain amyloid deposits are classical histopathological hallmarks that generate an …

Background Alzheimer's disease (AD) is the core cause of dementia in elderly populations.
One of the main hallmarks of AD is extracellular amyloid beta (Aβ) accumulation (APP …

Although the impact of aging on the function of the central nervous system is known, only a
limited amount of information is available about accompanying changes affecting the …

Emerging evidence have posited that dysregulated microglia impair clearance and
containment of amyloid‐β (Aβ) species in the brain, resulting in aberrant buildup of Aβ and …

The hippocampus and olfactory bulb incorporate new neurons migrating from neurogenic
regions in the brain. Hippocampal atrophy is evident in numerous neurodegenerative …

Phospholipid levels are reported to be decreased in Alzheimer's disease (AD). For a better
understanding, we investigated the time-dependent changes of phospholipids species in a …

Background: Several proteins have been identified as potential diagnostic biomarkers in
imaging, genetic, or proteomic studies in Alzheimer disease (AD) patients and mouse …